vs
ICU MEDICAL INC（ICUI）与世纪互联（VNET）财务数据对比。点击上方公司名可切换其他公司
ICU MEDICAL INC的季度营收约是世纪互联的1.5倍（$540.7M vs $362.7M），ICU MEDICAL INC净利率更高（-2.9% vs -10.7%，领先7.8%），ICU MEDICAL INC自由现金流更多（$36.0M vs $-193.1M），过去两年世纪互联的营收复合增速更高（17.4% vs -2.3%）
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
VNET Group即世纪互联，是中国领先的第三方中立数据中心服务商，提供机柜托管、云基础设施、混合云部署及网络管理等解决方案，服务覆盖科技、金融、零售等多领域企业客户，为企业数字化运营提供稳定的算力与网络支撑。
ICUI vs VNET — 直观对比
营收规模更大
ICUI
是对方的1.5倍
$362.7M
净利率更高
ICUI
高出7.8%
-10.7%
自由现金流更多
ICUI
多$229.0M
$-193.1M
两年增速更快
VNET
近两年复合增速
-2.3%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $540.7M | $362.7M |
| 净利润 | $-15.7M | $-38.7M |
| 毛利率 | 37.5% | 20.9% |
| 营业利润率 | 1.0% | 0.5% |
| 净利率 | -2.9% | -10.7% |
| 营收同比 | -14.1% | — |
| 净利润同比 | 34.0% | — |
| 每股收益（稀释后） | $-0.63 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ICUIVNET
| Q4 25 | $540.7M | — | ||
| Q3 25 | $537.0M | $362.7M | ||
| Q2 25 | $548.9M | — | ||
| Q1 25 | $604.7M | $309.5M | ||
| Q4 24 | $629.8M | — | ||
| Q3 24 | $589.1M | $302.2M | ||
| Q2 24 | $596.5M | $274.4M | ||
| Q1 24 | $566.7M | $262.9M |
净利润ICUIVNET
| Q4 25 | $-15.7M | — | ||
| Q3 25 | $-3.4M | $-38.7M | ||
| Q2 25 | $35.3M | — | ||
| Q1 25 | $-15.5M | $-2.4M | ||
| Q4 24 | $-23.8M | — | ||
| Q3 24 | $-33.0M | $-2.1M | ||
| Q2 24 | $-21.4M | $-1.1M | ||
| Q1 24 | $-39.5M | $-22.0M |
毛利率ICUIVNET
| Q4 25 | 37.5% | — | ||
| Q3 25 | 37.4% | 20.9% | ||
| Q2 25 | 37.9% | — | ||
| Q1 25 | 34.7% | 25.2% | ||
| Q4 24 | 36.1% | — | ||
| Q3 24 | 34.8% | 23.2% | ||
| Q2 24 | 34.8% | 21.3% | ||
| Q1 24 | 32.7% | 21.6% |
营业利润率ICUIVNET
| Q4 25 | 1.0% | — | ||
| Q3 25 | 2.6% | 0.5% | ||
| Q2 25 | 1.9% | — | ||
| Q1 25 | 2.1% | 0.1% | ||
| Q4 24 | 6.0% | — | ||
| Q3 24 | 1.4% | 24.5% | ||
| Q2 24 | 1.3% | 0.2% | ||
| Q1 24 | -1.9% | 0.2% |
净利率ICUIVNET
| Q4 25 | -2.9% | — | ||
| Q3 25 | -0.6% | -10.7% | ||
| Q2 25 | 6.4% | — | ||
| Q1 25 | -2.6% | -0.8% | ||
| Q4 24 | -3.8% | — | ||
| Q3 24 | -5.6% | -0.7% | ||
| Q2 24 | -3.6% | -0.4% | ||
| Q1 24 | -7.0% | -8.4% |
每股收益（稀释后）ICUIVNET
| Q4 25 | $-0.63 | — | ||
| Q3 25 | $-0.14 | — | ||
| Q2 25 | $1.43 | — | ||
| Q1 25 | $-0.63 | — | ||
| Q4 24 | $-0.97 | — | ||
| Q3 24 | $-1.35 | — | ||
| Q2 24 | $-0.88 | — | ||
| Q1 24 | $-1.63 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $492.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.1B | $890.8M |
| 总资产 | $4.1B | $6.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ICUIVNET
| Q4 25 | — | — | ||
| Q3 25 | — | $492.1M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $544.3M | ||
| Q4 24 | $308.6M | — | ||
| Q3 24 | $312.5M | $219.5M | ||
| Q2 24 | $302.6M | $247.2M | ||
| Q1 24 | $251.4M | $246.9M |
总债务ICUIVNET
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ICUIVNET
| Q4 25 | $2.1B | — | ||
| Q3 25 | $2.1B | $890.8M | ||
| Q2 25 | $2.1B | — | ||
| Q1 25 | $2.0B | $927.8M | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $2.0B | $902.9M | ||
| Q2 24 | $2.0B | $900.6M | ||
| Q1 24 | $2.1B | $895.1M |
总资产ICUIVNET
| Q4 25 | $4.1B | — | ||
| Q3 25 | $4.1B | $6.1B | ||
| Q2 25 | $4.1B | — | ||
| Q1 25 | $4.2B | $5.4B | ||
| Q4 24 | $4.2B | — | ||
| Q3 24 | $4.3B | $4.3B | ||
| Q2 24 | $4.3B | $4.0B | ||
| Q1 24 | $4.3B | $3.9B |
负债/权益比ICUIVNET
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.28× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.6M | $113.8M |
| 自由现金流经营现金流 - 资本支出 | $36.0M | $-193.1M |
| 自由现金流率自由现金流/营收 | 6.6% | -53.2% |
| 资本支出强度资本支出/营收 | 4.6% | 84.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $91.8M | $-589.7M |
8季度趋势，按日历期对齐
经营现金流ICUIVNET
| Q4 25 | $60.6M | — | ||
| Q3 25 | $56.7M | $113.8M | ||
| Q2 25 | $11.2M | — | ||
| Q1 25 | $51.3M | $27.0M | ||
| Q4 24 | $40.2M | — | ||
| Q3 24 | $36.1M | $108.3M | ||
| Q2 24 | $82.0M | $55.8M | ||
| Q1 24 | $45.8M | $37.1M |
自由现金流ICUIVNET
| Q4 25 | $36.0M | — | ||
| Q3 25 | $27.6M | $-193.1M | ||
| Q2 25 | $-8.5M | — | ||
| Q1 25 | $36.7M | $-220.0M | ||
| Q4 24 | $16.1M | — | ||
| Q3 24 | $16.2M | $-95.0M | ||
| Q2 24 | $62.5M | $-81.6M | ||
| Q1 24 | $29.9M | $-102.2M |
自由现金流率ICUIVNET
| Q4 25 | 6.6% | — | ||
| Q3 25 | 5.1% | -53.2% | ||
| Q2 25 | -1.5% | — | ||
| Q1 25 | 6.1% | -71.1% | ||
| Q4 24 | 2.6% | — | ||
| Q3 24 | 2.7% | -31.4% | ||
| Q2 24 | 10.5% | -29.8% | ||
| Q1 24 | 5.3% | -38.9% |
资本支出强度ICUIVNET
| Q4 25 | 4.6% | — | ||
| Q3 25 | 5.4% | 84.6% | ||
| Q2 25 | 3.6% | — | ||
| Q1 25 | 2.4% | 79.8% | ||
| Q4 24 | 3.8% | — | ||
| Q3 24 | 3.4% | 67.3% | ||
| Q2 24 | 3.3% | 50.1% | ||
| Q1 24 | 2.8% | 53.0% |
现金转化率ICUIVNET
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.32× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
VNET
暂无分部数据
